SALEMI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 20.338
EU - Europa 11.212
AS - Asia 9.135
SA - Sud America 1.316
AF - Africa 304
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 18
Totale 42.367
Nazione #
US - Stati Uniti d'America 20.035
SG - Singapore 3.137
IT - Italia 2.773
RU - Federazione Russa 2.756
CN - Cina 2.380
FI - Finlandia 1.128
BR - Brasile 1.027
HK - Hong Kong 927
UA - Ucraina 895
DE - Germania 871
VN - Vietnam 823
PL - Polonia 586
GB - Regno Unito 537
FR - Francia 454
IE - Irlanda 389
JP - Giappone 331
BD - Bangladesh 305
KR - Corea 273
IN - India 228
SE - Svezia 218
NL - Olanda 151
CA - Canada 150
IQ - Iraq 118
AR - Argentina 109
TR - Turchia 107
IR - Iran 103
BE - Belgio 94
RO - Romania 87
MX - Messico 79
ES - Italia 63
AT - Austria 62
CI - Costa d'Avorio 55
ZA - Sudafrica 52
PK - Pakistan 51
MA - Marocco 48
UZ - Uzbekistan 48
EG - Egitto 45
VE - Venezuela 41
ID - Indonesia 40
EC - Ecuador 36
AU - Australia 31
SA - Arabia Saudita 31
KE - Kenya 30
CH - Svizzera 28
MY - Malesia 28
CO - Colombia 26
PH - Filippine 26
JO - Giordania 25
PY - Paraguay 23
CL - Cile 22
CZ - Repubblica Ceca 21
NP - Nepal 21
GR - Grecia 20
KZ - Kazakistan 20
LT - Lituania 19
TN - Tunisia 17
AE - Emirati Arabi Uniti 16
DZ - Algeria 16
AZ - Azerbaigian 15
JM - Giamaica 15
ET - Etiopia 14
EU - Europa 14
HN - Honduras 14
LB - Libano 12
PE - Perù 12
CR - Costa Rica 11
NZ - Nuova Zelanda 11
IL - Israele 9
KG - Kirghizistan 9
TW - Taiwan 9
BO - Bolivia 8
GE - Georgia 8
OM - Oman 8
PA - Panama 8
SN - Senegal 8
UY - Uruguay 8
AL - Albania 7
MD - Moldavia 7
DO - Repubblica Dominicana 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
BY - Bielorussia 5
HU - Ungheria 5
RS - Serbia 5
TH - Thailandia 5
BG - Bulgaria 4
DK - Danimarca 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CG - Congo 3
GT - Guatemala 3
GY - Guiana 3
HR - Croazia 3
KW - Kuwait 3
MM - Myanmar 3
NG - Nigeria 3
NI - Nicaragua 3
PR - Porto Rico 3
EE - Estonia 2
Totale 42.329
Città #
Ashburn 2.546
Fairfield 2.258
Singapore 2.120
Houston 1.207
San Jose 1.166
Woodbridge 1.153
Chandler 1.014
Seattle 915
Hong Kong 875
Wilmington 872
Ann Arbor 781
Cambridge 728
Palermo 527
Zgierz 517
Moscow 507
Jacksonville 473
Dublin 380
Medford 360
Beijing 348
Des Moines 321
Tokyo 313
Dallas 296
Ho Chi Minh City 291
Santa Clara 291
Frankfurt am Main 274
Los Angeles 274
Nanjing 265
Boardman 248
Lauterbourg 239
New York 234
Princeton 227
Council Bluffs 224
Hefei 223
Altamura 194
Hanoi 188
Dearborn 179
Lawrence 159
Milan 153
Tulsa 137
Buffalo 126
The Dalles 125
San Diego 120
Rome 106
Helsinki 102
Shenyang 100
Ludwigshafen am Rhein 96
São Paulo 93
Changsha 89
London 88
Seoul 84
Brussels 83
Jinan 82
Nanchang 72
Chicago 71
Tianjin 67
Hebei 64
Amsterdam 57
Seongnam 56
Abidjan 54
Nuremberg 54
Columbus 53
Baghdad 50
Orem 50
Saint Petersburg 47
Montreal 43
Phoenix 43
Atlanta 42
Jiaxing 42
Da Nang 41
Guangzhou 41
San Paolo di Civitate 40
Hangzhou 38
Tashkent 38
Tehran 38
Venice 38
Chennai 37
Haiphong 36
Johannesburg 36
Toronto 36
Brooklyn 35
Munich 35
Ningbo 35
Norwalk 35
Warsaw 35
Foggia 34
Stockholm 33
Verona 32
Ankara 30
San Mateo 30
Washington 30
Kumar 29
Naples 29
Rio de Janeiro 29
Vienna 29
Zhengzhou 29
Düsseldorf 27
Denver 25
City of London 23
Hải Dương 23
Mumbai 23
Totale 26.685
Nome #
Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients 364
Quantitative EEG differentiate Multiple Sclerosis with and without Cognitive Impairment from healthy controls at the beginning of the disease: preliminary data 351
Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: A cohort study 283
A validation study of an Italian version of the "ID Migraine". 282
A Low Repeat Length in Oligodendrocyte Chromatin 273
Diabetic and non-diabetic subjects with ischemic stroke: Differences, subtype distribution and outcome 268
Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study 268
Effect of extracellular vesicles from CSF of multiple sclerosis patients and healthy controls on astrocytes in culture 260
VDBP, CYP27B1, and 25-Hydroxyvitamin D Gene Polymorphism Analyses in a Group of Sicilian Multiple Sclerosis Patients 260
A population-based survey of cognitive performance in a Sicilian elderly community. 257
Klotho and vitamin D in multiple sclerosis: an Italian study 255
Age at menopause predicts age at onset of Parkinson's disease. 249
Fumo, caffè e rischio di Sclerosi Multipla: uno studio caso-controllo 249
Cathodal Occipital tDCS is unable to modulate The Sound Induced Flash Illusion in migraine 249
Application of tRNS to improve multiple sclerosis fatigue: a pilot, single-blind, sham-controlled study 249
Clinical features, disease course and prognosis in patients with paediatric and young adult onset multiple sclerosis 245
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 245
Multiple Sclerosis Severity Score using disability and disease duration to rate disease severity 241
Differences in intercellular communication during clinical relapse and gadolinium-enhanced MRI in patients with relapsing remitting multiple sclerosis: A study of the composition of extracellular vesicles in cerebrospinal fluid 241
Neuronavigation-guided biopsy for differential diagnosis of pseudotumoral demyelinating brain lesions 237
The Italian multiple sclerosis register 237
The relapse rate of multiple sclerosis changes during pregnancy: a cohort study 234
Risk of Parkinson disease in women: effect of reproductive characteristics 233
Association of CYP2R1 rs10766197 with MS risk and disease progression 233
Blood Lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients 232
A validation study of an Italian version of the ID migraine: preliminary results. 232
Anodal tDCS of the swallowing motor cortex for treatment of dysphagia in multiple sclerosis: a pilot open-label study 231
A CASE-CONTROL STUDY ON THE ASSOCIATION BETWEEN DIABETES AND PD 225
Search for genetic factors associated with susceptibility to multiple sclerosis. 224
Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. 224
Quantitative EEG differentiates multiple sclerosis with and without cognitive impairment from healthy controls at the beginning of the disease: preliminary data 223
A CASE OF JUVENILE STROKE CAUSED BY ACTINIC CERVICAL ARTERIOPATHY 222
Prognostic indicators in pediatric clinically isolated syndrome 222
LEVETIRACETAM IN THE TREATMENT OF VASCULAR CHOREA: A CASE REPORT 219
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. 219
Binding of flunitrazepam to differentiating neurons cultured in a chemically defined, hormone-supplemented medium 219
Blood levels of homocysteine, cysteine, glutathione, folic acid, and vitamin B(12) in the acute phase of atherothrombotic stroke. 217
Multiple sclerosis survival: a population-based study in Sicily. 217
Rates and correlates of suicidal ideation among stroke survivors: a meta-analysis 217
Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies 214
A validation study of an italian version of the ID Migraine: preliminary results 213
BODY MASS INDEX DOES NOT CHANGE BEFORE PARKINSON'S DISEASE ONSET. 213
Clinical Use of κ Free Light Chains Index as a Screening Test for Multiple Sclerosis 212
A VALIDATION STUDY OF AN ITALIAN VERSION OF THE “ID MIGRAINE” 211
A screening instrument for a Sicilian neuroepidemiological survey in the elderly 210
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis 207
Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. 207
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. 206
Application of tRNS to improve Multiple Sclerosis Fatigue: a sham-controlled study 205
Migraine and Sport in a Physically Active Population of Students: Results of a Cross‐Sectional Study 205
Determinants of depressive symptoms among spouse caregivers of patients with Parkinson's disease 203
Analisi dei Polimorfismi di Citochine Th2 nella Sclerosi Multipla. 203
Diabetes preceding Parkinson's disease onset. A case-control study 203
A case control study to evaluate the relationship between cigarette smoking or coffee consumption and multiple sclerosis 201
Multiple sclerosis in southern Europe: Monreale City, Italy. A twenty-year follow-up incidence and prevalence study 200
Extracellular vesicles isolated by cerebrospinal fluid as biomarkers of inflammation in multiple sclerosis and inflammatory neurological diseases. 200
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study. 199
Age at onset of parkinson's disease in women is associated with age at menopause. 198
The HLA locus and multiple sclerosis in Sicily 197
First-ever stroke incidence and 30-day case fatality in the Sicilian Aeolian archipelago, Italy 197
Determinants of depressive symptoms among spouse caregivers of patients with Parkinson’s disease 197
Accuracy of death certificates for motor neuron disease and multiple sclerosis in the province of Palermo in southern Italy 197
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study). 194
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis 193
PECULIARE EVOLUZIONE DELLA SEMEIOTICA NEURORADIOLOGICA DI UN CASO DI MALATTIA DEMIELINIZZANTE CON LESIONI PSEUDOTUMORALI 193
A post-marketing comparison study on disability modification in progressive multiple sclerosis after interferon beta-1b or mitoxantrone therapy 189
Treatment of multiple sclerosis with interferon beta in clinical practice: 2-year follow-up data from the South Italy Mobile MRI Project. 189
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study. 188
Effects of transcranial random noise stimulation combined with Graded Repetitive Arm Supplementary Program (GRASP) on motor rehabilitation of the upper limb in sub-acute ischemic stroke patients: a randomized pilot study. 188
Depression and associated factors among spouse-caregivers of patient with Parkinson’s disease 187
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers 187
Expression of synapsin I gene in primary cultures of differentiating rat cortical neurons 187
A SPG4 GENE MUTATION CAUSES AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA IN AN ITALIAN FAMILY 186
Autosomal dominant hereditary spastic paraplegia: report of a large italian family with R581X spastin mutation. 186
HIGH PREVALENCE AND FAST RISING INCIDENCE OF MULTIPLE SCLEROSIS IN CALTANISSETTA, SICILY, SOUTHERN ITALY. 186
Brain atrophy and lesion load in a large population of patients with multiple sclerosis 186
A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis 186
Identification of the novel D297fsX318 PINK1 mutation and phenotype variation in a family with early onset Parkinson’s disease 184
Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients 184
remarkably increasing incidence of multiple sclerosis. A follow-up study in Caltanissetta, Sicily 183
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases 182
Amyotrophic lateral sclerosis in Palermo, Italy: an epidemiological study 182
Extracellular vesicles from CS fluid are possible biomarkers of multiple sclerosis disease status 182
Remarkably increasing incidence of Multiple Sclerosis. A follow-up study in calatanissetta, Sicily 181
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. 181
Rat CNS neurons are not yet programmed to shorten their chromatin repeat length at the end of fetal neurogenesis 181
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 181
Dentatorubral-pallidoluysian atrophy: Haplotype of Asian origin in 2 Italian families. 180
Identification of Biomarkers in Cerebrospinal Fluid and Serum of Multiple Sclerosis Patients by Immunoproteomics Approach 178
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. 178
Tumor diagnosis preceding Parkinson's disease: a case-control study. 177
Clinical features and disease out come in patients with pediatric and young adult onset Multiple Sclerosis 177
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience. 177
A Door-to-Door population based survey on cognitive performance In Bagheria, Sicily. 177
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population 176
SIMULTANEOUS DETERMINATION OF ATP, ITS METABOLITES AND NAD+ IN BLOOD BY HPLC WITH PHOTODIODE ARRAY DETECTOR 174
Hypoxanthine and purine compounds in plasma from patients with multiple sclerosis and psoriasis 174
IMMUNOSUPPRESSANT TREATMENT AND CANCER RISK IN A COHORT OF PATIENTS AFFECTED BY MULTIPLE SCLEROSIS 174
Further evidence of genetic heterogeneity in familial essential tremor. 173
High-intensity interval training improves bone remodeling, lipid profile, and physical function in multiple sclerosis patients 172
Totale 21.237
Categoria #
all - tutte 150.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.241


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021326 0 0 0 0 0 0 0 0 0 0 0 326
2021/20222.562 144 656 57 81 82 72 139 126 288 323 134 460
2022/20233.635 347 598 67 300 465 541 251 243 372 184 194 73
2023/20241.879 92 262 178 168 172 301 172 122 34 61 39 278
2024/20254.747 172 350 309 432 178 133 318 275 383 506 564 1.127
2025/202615.846 1.167 434 1.022 1.166 1.439 2.268 2.136 1.729 1.292 2.086 795 312
Totale 43.442